Determining carboplatin/etoposide dosage in extensive stage small-cell lung cancer (SCLC)

Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.

1987 • 114 citations

Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.

1987 • 96 citations

Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.

1987 • 87 citations

Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus

1989 • 57 citations

VP-16 and carboplatin in previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group

1988 • 34 citations

Carboplatin (JM8) as a single agent and in combination in the treatment of small cell lung cancer

1985 • 33 citations